World Health Organization Issues Alert Over Acute Shortage of Weight-Loss Medications
Fewer than a tenth of patients that would benefit from weight-loss injections like Wegovy can access them, states the WHO as it publishes its first advice on the therapies.
Considering in excess of 1,000,000,000 people worldwide currently living with obesity, it is urging broader and more equitable access to these injectable treatments.
Based on projections, more than two billion could be obese by 2030 unless action is taken.
"The latest guidance acknowledges that obesity is a chronic disease that can be managed with comprehensive and continuous treatment," remarked the agency's head Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and supply-chain constraints are major hurdles to universal availability to the injections that can help people shift considerable weight, explains the body.
Skinny Jab Shortage
Even under the present most optimistic scenario, the supply of GLP-1 therapies might only reach approximately 100 million people – fewer than 10% of eligible patients, according to the WHO.
The recommendation calls on nations and manufacturers to increase access, through approaches such as licensing agreements.
Exclusive production rights on semaglutide – the main ingredient of a leading brand – is scheduled to end in a number of nations in 2026.
How Obesity Injections Function
The injections imitate a natural hormone to reduce digestion speed, reduce hunger and enhance satiety so people reduce food intake.
Patients usually see weight reduction within a few weeks of starting on the weekly injections.
Studies indicates people may regain a significant portion a year later of discontinuing the medication, when their usual hunger return.
To be above a healthy weight increases your chance for contracting diseases, such as diabetes, cardiovascular issues, stroke, and certain malignancies.
Obesity concerns individuals in countries worldwide and was responsible for millions of deaths worldwide in 2024, per the health agency.
